Comparative Study
Studies on the mechanism of action of 5-aziridinyl-2, 4-dinitrobenzamide in tumor cells
- PMID: 4855748
Item in Clipboard
Comparative Study
Studies on the mechanism of action of 5-aziridinyl-2, 4-dinitrobenzamide in tumor cells
Cancer Res.
1974 Feb.
No abstract available
Similar articles
-
[Metabolic behavior of tumor slices under the influence of cytostatic compounds].Hoppe Seylers Z Physiol Chem. 1969 Jul;350(7):803-8. Hoppe Seylers Z Physiol Chem. 1969. PMID: 5806554 German. No abstract available.
-
[Studies on the mechanism of cytostatic action of methylhydrazine, II].Hoppe Seylers Z Physiol Chem. 1967 Apr;348(4):433-42. Hoppe Seylers Z Physiol Chem. 1967. PMID: 5587962 German. No abstract available.
-
The mechanism of action of the epidermal growth factor. 3. Stimulation of the uptake of labeled precursors into RNA, DNA and proteins induced by EGF in isolated tumor cells.Hormones. 1972;3(3):183-91. Hormones. 1972. PMID: 4676050 No abstract available.
-
[On the problem of praetherapeutic sensitivity testing of human tumours based on incorporation studies of nucleic acid precursors in vitro (author's transl)].Klin Wochenschr. 1977 Dec 1;55(23):1127-36. doi: 10.1007/BF01478050. Klin Wochenschr. 1977. PMID: 340776 Review. German.
-
The metabolic basis for combination chemotherapy.Pharmacol Ther. 1988;38(1):73-127. doi: 10.1016/0163-7258(88)90103-9. Pharmacol Ther. 1988. PMID: 3293090 Review. No abstract available.
Cited by
-
Proceedings: Protection against the cytotoxic aziridine CB1954 by an arylimidazole with anti-inflammatory activity.Br J Cancer. 1975 Aug;32(2):244. doi: 10.1038/bjc.1975.169. Br J Cancer. 1975. PMID: 1212363 Free PMC article. No abstract available.
-
Effect of vitamin A on methotrexate cytotoxicity in L1210 murine leukemia cells in culture.Cancer Chemother Pharmacol. 1993;32(4):263-7. doi: 10.1007/BF00686170. Cancer Chemother Pharmacol. 1993. PMID: 8324867
-
Enhanced cytotoxicity with methotrexate in conjunction with hypoxanthine in L1210 cells in culture.Cancer Chemother Pharmacol. 1988;22(1):26-32. doi: 10.1007/BF00254176. Cancer Chemother Pharmacol. 1988. PMID: 3396144
-
CB 1954 revisited. II. Toxicity and antitumour activity.Cancer Chemother Pharmacol. 1986;16(1):9-14. doi: 10.1007/BF00255279. Cancer Chemother Pharmacol. 1986. PMID: 3940225
-
CB 1954 revisited. I. Disposition kinetics and metabolism.Cancer Chemother Pharmacol. 1986;16(1):1-8. doi: 10.1007/BF00255278. Cancer Chemother Pharmacol. 1986. PMID: 3940216